Home>>Association of increased dermatologist density with lower melanoma mortality.

Search

About

Authors:
Address: Department of Dermatology, University Hospitals Case Medical Center, and School of Medicine, Case Western Reserve University, Cleveland, OH 44124, USA.
Journal:


Publication:


abstract

OBJECTIVE:

To determine whether there is an Association between dermatologist density and melanoma mortality.

DESIGN:

A regression model was developed to test the association between melanoma mortality and dermatologist density, controlling for county demographics, health care infrastructure, and socioeconomic factors. Data were collected from the Area Resource File, US Centers for Disease Control and Prevention, and National Cancer Institute's Surveillance, Epidemiology, and End Results program and National Program for Cancer Registries.

SETTING:

US counties.

PATIENTS:

Melanoma mortality and incidence data were reported as age-adjusted mean rates per 100 000 people from January 2002, through December 2006.

MAIN OUTCOME MEASURE:

The primary outcome measure was melanoma mortality rate per 100 000 people at the county level.

RESULTS:

Geographic variation exists in the distribution of dermatologists across the United States. Multivariate analysis demonstrated that the presence of 0.001 to 1 dermatologist per 100 000 people was associated with a 35.0% reduction in the melanoma mortality rate (95% CI, 13.4%-56.6%) when compared with counties with no dermatologist. The presence of 1.001 to 2 dermatologists per 100 000 people was associated with a 53.0% reduction in the melanoma mortality rate (95% CI, 30.6%-75.4%). Having more than 2 dermatologists per 100 000 people did not further lower melanoma mortality rates.

CONCLUSION:

Within a given county, a greater dermatologist density is associated with lower melanoma mortality rates compared with counties that lacked a dermatologist.



Related Articles
Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Arch Dermatol. 2007
Melanoma outcomes for Medicare patients: association of stage and survival with detection by a dermatologist vs a nondermatologist.
Pennie ML, Soon SL, Risser JB, Veledar E, Culler SD, Chen SC. Arch Dermatol. 2007 Apr; 143(4):488-94.
The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993.
J Am Acad Dermatol. 2009
The association of physician-specialty density and melanoma prognosis in the United States, 1988 to 1993.
Eide MJ, Weinstock MA, Clark MA. J Am Acad Dermatol. 2009 Jan; 60(1):51-8. Epub 2008 Oct 19.
Effects of physician supply on melanoma incidence and mortality in Florida.
South Med J. 2003
Effects of physician supply on melanoma incidence and mortality in Florida.
Van Durme DJ, Ullman R, Campbell RJ, Roetzheim R. South Med J. 2003 Jul; 96(7):656-60.
Review Incidence, mortality and survival in cutaneous melanoma.
J Plast Reconstr Aesthet Surg....
Review Incidence, mortality and survival in cutaneous melanoma.
Giblin AV, Thomas JM. J Plast Reconstr Aesthet Surg. 2007; 60(1):32-40. Epub 2006 Jul 7.
Review Cutaneous melanoma.
Cancer Surv. 1994
Review Cutaneous melanoma.
Armstrong BK, Kricker A. Cancer Surv. 1994; 19-20:219-40.